Japanese CRO JCL Bioassay To Go Public On Osaka Stock Exchange
This article was originally published in PharmAsia News
Osaka-based Japan Clinic Laboratories Bioassay, a clinical and non-clinical trial contract drug concentration testing company, will go public March 17. The company shares will be listed on Osaka Stock Exchange's Hercules Market. JCL Bioassay plans to invest the raised funds in establishing a research institute in the U.S. (Click here for more - Japanese language
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.